High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia

被引：0
作者：
Jun Li
Zheng Ge
机构：
[1] Medical School of Southeast University,Department of Hematology, Zhongda Hospita
[2] Institute of Hematology Southeast University,Hershey Medical Center
[3] Pennsylvania State University Medical College,undefined
来源：
BMC Cancer | / 21卷
关键词：
AML; Prognosis; Biomarker; Oncogene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia
    Dang, Harry
    Chen, Yan
    Kamel-Reid, Suzanne
    Brandwein, Joseph
    Chang, Hong
    HUMAN PATHOLOGY, 2013, 44 (10) : 2038 - 2046
  • [32] Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia
    Müller-Tidow, C
    Metzelder, SK
    Buerger, H
    Packeisen, J
    Ganser, A
    Heil, G
    Kugler, K
    Adigüzel, G
    Schwäble, J
    Steffen, B
    Ludwig, WD
    Heinecke, A
    Büchner, T
    Berdel, WE
    Serve, H
    LEUKEMIA, 2004, 18 (04) : 720 - 726
  • [33] Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia
    C Müller-Tidow
    S K Metzelder
    H Buerger
    J Packeisen
    A Ganser
    G Heil
    K Kügler
    G Adigüzel
    J Schwäble
    B Steffen
    W-D Ludwig
    A Heinecke
    T Büchner
    W E Berdel
    H Serve
    Leukemia, 2004, 18 : 720 - 726
  • [34] High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia
    Fang, Zhigang
    Wang, Xiaozhen
    Wu, Jieying
    Xiao, Ruozhi
    Liu, Jiajun
    CANCER BIOMARKERS, 2020, 27 (01) : 1 - 9
  • [35] Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity
    Ahn, Hee Kyung
    Jang, Jun Ho
    Kim, Kihyun
    Kim, Hee-Jin
    Kim, Sun-Hee
    Jung, Chul Won
    Kim, Dong Hwan
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 37 - 41
  • [36] High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia
    Yang, Lu
    Chen, Wen-Min
    Dao, Feng-Ting
    Zhang, Yan-Huan
    Wang, Ya-Zhe
    Chang, Yan
    Liu, Yan-Rong
    Jiang, Qian
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Qin, Ya-Zhen
    CANCER MEDICINE, 2019, 8 (12): : 5459 - 5467
  • [37] Gene expression and prognosis in acute myeloid leukemia
    Bullinger, L.
    Doehner, K.
    Frohling, St.
    Schlenk, R. F.
    Pollack, J. R.
    Doehner, H.
    ANNALS OF HEMATOLOGY, 2008, 87 : S35 - S37
  • [38] Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
    Yang Cao
    Yue Liu
    Limei Shang
    Huijuan Chen
    Yanhua Yue
    Weimin Dong
    Yanting Guo
    Haonan Yang
    Xiaojun Yang
    Yan Liu
    Weiying Gu
    Xiaoying Zhang
    International Journal of Clinical Oncology, 2022, 27 : 1222 - 1232
  • [39] Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
    Cao, Yang
    Liu, Yue
    Shang, Limei
    Chen, Huijuan
    Yue, Yanhua
    Dong, Weimin
    Guo, Yanting
    Yang, Haonan
    Yang, Xiaojun
    Liu, Yan
    Gu, Weiying
    Zhang, Xiaoying
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1222 - 1232
  • [40] lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia
    Chen, Cunte
    Wang, Peipei
    Mo, Wenjian
    Zhang, Yuping
    Zhou, Wei
    Deng, Tingfen
    Zhou, Ming
    Chen, Xiaowei
    Wang, Shunqing
    Wang, Caixia
    ONCOLOGY LETTERS, 2019, 18 (03) : 2203 - 2211
12345